findmyKOL

Nathan Staff, MD

Enriched profile

Mayo Clinic in Rochester

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyNeurologyFocusPeripheral Neuropathies and Disorders+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2023–2025NIH funding2012–2026

Nathan Staff is a Peripheral Neuropathies and Disorders physician affiliated with Mayo Clinic in Rochester. OpenAlex indexes 194 publications with 7,781 citations (h-index 43); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 23 Oct 2026

Overview

Updated 24 Oct 2026

Nathan Staff, M.D., is affiliated with Mayo Clinic in Rochester, Minnesota. The public record shows 194 publications with 7,781 citations (h-index 43), centered on Peripheral Neuropathies and Disorders, Amyotrophic Lateral Sclerosis Research, Cancer Treatment and Pharmacology. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 3 companies, 5 NIH-funded awards (2012–2026).

  • Most recent indexed publication: 2026 · Neurology
  • Top research focus: Peripheral Neuropathies and Disorders
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ALS1 trialMotor Neuron Disease1 trial

Research focus

OpenAlex concept fingerprint
Peripheral Neuropathies and DisordersAmyotrophic Lateral Sclerosis ResearchCancer Treatment and PharmacologyHereditary Neurological DisordersPeripheral Nerve Disorders

Drugs & molecules

across trials, industry payments and publications
Nexplanongeneric · EtonogestrelClinical trials—Industry payments1Publications—Radicavageneric · EdaravoneClinical trials—Industry payments1Publications—Vyvgartgeneric · Efgartigimod alfaClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Argenx Us, Inc.Clinical trials—Industry payments1Mayo ClinicClinical trials1Industry payments—Mitsubishi Tanabe Pharma America, Inc.Clinical trials—Industry payments1Organon LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
194publications

Distinct works indexed by OpenAlex, matched via ORCID; 29 in PubMed.

7,781citations

Total citations across indexed works.

43h-index

Hirsch index (OpenAlex). i10-index 89.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
3companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 2012–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 24 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 24 Oct 2026

3 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    81.5%
    Other nervous system drugs43.1%
    Radicava Ors100%
    Part D<11 patients
    Gabapentinoids21.5%
    Gabapentin100%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    18.5%
    Anticholinergic18.5%
    Scopolamine100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 24 Oct 2026

5 NIH research awards on record, funded 2012–2026 per NIH RePORTER. The latest:

Congress activity

Updated 24 Oct 2026

2 congress contributions (2015–2019) across ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 24 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 24 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Christopher J. Klein36Anthony J. Windebank30P. James B. Dyck21Michelle L. Mauermann20Divyanshu Dubey15Jennifer M. Martinez‐Thompson15Charles L. Loprinzi14Sybil Hrstka13Björn Oskarsson13Merit Cudkowicz12James D. Berry11Nicolas N. Madigan11Ruple S. Laughlin11Sarah E. Berini11Robert J. Spinner10Namita Goyal10Marcus Vinícius Pinto9Robert H. Brown9Margaret Ayo Owegi9E. Matthew Hoffman8Ron F. Hrstka8Surendra Dasari8Jonathan Katz8Matthew J. Burford7Rohit Budhraja7Akhilesh Pandey7Yaël Gothelf7Allan B. Dietz7Nicholas John Maragakis7Graeme J. Preston7Shahar Shelly7Kamal Shouman7Ibrahim Shammas7Tamás Kozicz7Janean K. Engelstad7Silvia Radenkovic7Kathryn J. Ruddy6Andreas S. Beutler6Elizabeth Smith6Stephen Carl Ekker6

Online presence

Updated 24 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    alumniassociation.mayo.edu

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →alumniassociation.mayo.edu ↗
  • Other

    ce.mayo.edu/node/179824

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ce.mayo.edu ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 24 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗

Awards & honors

honors on the public record

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.